PDB Short entry for 1R70 HEADER IMMUNE SYSTEM 17-OCT-03 1R70 TITLE MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING, CURVE FITTING TITLE 2 AND HOMOLOGY MODELLING COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN IGA2(M1) LIGHT CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HUMAN IGA2(M1) HEAVY CHAIN; COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HUMAN ALPHA 2 GENE (LIGHT CHAIN); SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: K1; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: CHINESE HAMSTER OVARY (CHO); SOURCE 11 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PEE6.HCMV; SOURCE 14 MOL_ID: 2; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 GENE: HUMAN ALPHA 2 GENE (HEAVY CHAIN); SOURCE 19 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 22 EXPRESSION_SYSTEM_STRAIN: K1; SOURCE 23 EXPRESSION_SYSTEM_CELL_LINE: CHINESE HAMSTER OVARY (CHO); SOURCE 24 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 25 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 26 EXPRESSION_SYSTEM_PLASMID: PEE6.HCMV KEYWDS IMMUNOLOGY, ANTIBODY, IGA, GLYCOPROTEIN, IG FOLD, IMMUNE SYSTEM EXPDTA SOLUTION SCATTERING MDLTYP CA ATOMS ONLY, CHAIN A, B, C, D AUTHOR P.B.FURTADO,P.W.WHITTY,A.ROBERTSON,J.T.EATON,A.ALMOGREN,M.A.KERR, AUTHOR 2 J.M.WOOF,S.J.PERKINS REVDAT 7 14-FEB-24 1R70 1 REMARK REVDAT 6 13-JUN-18 1R70 1 REMARK REVDAT 5 25-APR-18 1R70 1 REMARK REVDAT 4 11-OCT-17 1R70 1 REMARK REVDAT 3 07-APR-10 1R70 1 REMARK REVDAT 2 24-FEB-09 1R70 1 VERSN REVDAT 1 19-OCT-04 1R70 0 JRNL AUTH P.B.FURTADO,P.W.WHITTY,A.ROBERTSON,J.T.EATON,A.ALMOGREN, JRNL AUTH 2 M.A.KERR,J.M.WOOF,S.J.PERKINS JRNL TITL SOLUTION STRUCTURE DETERMINATION OF MONOMERIC HUMAN IGA2 BY JRNL TITL 2 X-RAY AND NEUTRON SCATTERING, ANALYTICAL ULTRACENTRIFUGATION JRNL TITL 3 AND CONSTRAINED MODELLING: A COMPARISON WITH MONOMERIC HUMAN JRNL TITL 4 IGA1. JRNL REF J.MOL.BIOL. V. 338 921 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15111057 JRNL DOI 10.1016/J.JMB.2004.03.007 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER REMARK 3 AUTHORS : REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R70 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020514. REMARK 265 REMARK 265 EXPERIMENTAL DETAILS REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : SRS BEAMLINE 2.1 REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : 2.1 REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : 500-CHANNEL QUADRANT REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.4 REMARK 265 NUMBER OF TIME FRAMES USED : 10 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 2-15 REMARK 265 SAMPLE BUFFER : DULBECCO PBS REMARK 265 DATA REDUCTION SOFTWARE : OTOKO REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.17 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.11 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 2.39 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.10 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : 1.37 REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.16 REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ESRF BEAMLINE ID02 REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : ID02 REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : FRELON CCD CAMERA REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.4 REMARK 265 NUMBER OF TIME FRAMES USED : 10 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 0.55-1.12 REMARK 265 SAMPLE BUFFER : DULBECCO PBS REMARK 265 DATA REDUCTION SOFTWARE : MULTICCD REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.18 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.09 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 2.47 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.09 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : 1.47 REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.08 REMARK 265 P(R) PROTEIN LENGTH (NM) : 16 REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ISIS REMARK 265 SYNCHROTRON (Y/N) : N REMARK 265 BEAMLINE TYPE : PULSED NEUTRON REMARK 265 BEAMLINE INSTRUMENT : LOQ REMARK 265 DETECTOR TYPE : AREA (TIME-OF-FLIGHT) REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.4 REMARK 265 NUMBER OF TIME FRAMES USED : NULL REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 2.0-3.0 REMARK 265 SAMPLE BUFFER : PBS IN 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : COLLETTE REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.03 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.01 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 2.21 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.10 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : 1.04 REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.06 REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 DATA ANALYSIS AND MODEL FITTING: REMARK 265 METHOD USED TO DETERMINE THE STRUCTURE: CONSTRAINED SCATTERING REMARK 265 FITTING OF HOMOLOGY MODELS REMARK 265 SOFTWARE USED : INSIGHT II, HOMOLOGY, DISCOVERY, BIOPOLYMER, REMARK 265 DELPHI, O, SCTPL7, GNOM REMARK 265 SOFTWARE AUTHORS : ACCELRYS REMARK 265 STARTING MODEL : NULL REMARK 265 REMARK 265 CONFORMERS, NUMBER CALCULATED : 10000 REMARK 265 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 265 CONFORMERS, SELECTION CRITERIA : THE MODELLED SCATTERING CURVES REMARK 265 WERE ASSESSED BY CALCULATION OF THE RG, RSX-1 AND VALUES IN THE REMARK 265 SAME Q RANGES USED IN THE EXPERIMENTAL GUINIER FITS. MODELS WERE REMARK 265 THEN RANKED USING A GOODNESS-OF-FIT R-FACTOR DEFINED BY ANALOGY REMARK 265 WITH PROTEIN CRYSTALLOGRAPHY AND BASED ON THE EXPERIMENTAL REMARK 265 CURVES IN THE Q RANGE EXTENDING TO 2.2 NM-1 (ESRF X-RAYS) AND REMARK 265 2.2 NM-1 (ISIS NEUTRONS). REMARK 265 REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 265 REMARK 265 OTHER DETAILS: HOMOLOGY MODELS WERE BUILT FOR THE IGA2 FAB AND FC REMARK 265 FRAGMENTS STARTING FROM THE IGA1 MODEL (PDB ENTRY 1IGA). THE REMARK 265 POSITIONS OF THE FAB FRAGMENTS RELATIVE TO THE FC FRAGMENT WERE REMARK 265 DETERMINED BY AN APPROACH THAT COMBINED RANDOM HINGE PEPTIDE REMARK 265 STRUCTURES PRODUCED BY MOLECULAR DYNAMICS SIMULATIONS WITH CURVE- REMARK 265 FITTING TO EXPERIMENTAL SOLUTION SCATTERING DATA. THE X-RAY AND REMARK 265 NEUTRON SCATTERING CURVE I(Q) WAS CALCULATED ASSUMING A UNIFORM REMARK 265 SCATTERING DENSITY FOR THE SPHERES USING THE DEBYE EQUATION AS REMARK 265 ADAPTED TO SPHERES. X-RAY CURVES WERE CALCULATED FROM THE REMARK 265 HYDRATED SPHERE MODELS WITHOUT CORRECTIONS FOR WAVELENGTH SPREAD REMARK 265 OR BEAM DIVERGENCE, WHILE THESE CORRECTIONS WERE APPLIED FOR THE REMARK 265 NEUTRON CURVES BUT NOW USING UNHYDRATED MODELS. A SINGLE REMARK 265 ARRANGEMENT OF THE FAB FRAGMENTS IS PRESENTED, WHICH IS REMARK 265 REPRESENTATIVE OF A FAMILY OF STRUCTURES THAT FIT THE SCATTERING REMARK 265 DATA. MORE DETAILS ON THE MODELLING STRATEGY ARE CONTAINED IN REMARK 265 THE PRIMARY REFERENCE. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VGE RELATED DB: PDB REMARK 900 HUMAN IGG1 TR1_9 FAB. USED AS TEMPLATE FOR VL, CL AND VH DOMAINS REMARK 900 RELATED ID: 2FBJ RELATED DB: PDB REMARK 900 MOUSE IGA JS39 FAB. USED AS TEMPLATE FOR CH1 DOMAIN REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 HUMAN IGG FC (CHAIN A). USED AS TEMPLATE FOR CH2 AND CH3 DOMAINS REMARK 999 REMARK 999 SEQUENCE REMARK 999 AT THE TIME OF PROCESSING, THERE WERE NO REMARK 999 SUITABLE SEQUENCE DATABASE REFERENCES FOR REMARK 999 THE PROTEINS IN THIS ENTRY. DBREF 1R70 A 1 214 PDB 1R70 1R70 1 214 DBREF 1R70 B 215 676 PDB 1R70 1R70 215 676 DBREF 1R70 C 677 890 PDB 1R70 1R70 677 890 DBREF 1R70 D 891 1352 PDB 1R70 1R70 891 1352 SEQRES 1 A 214 GLU LEU VAL MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 A 214 SER VAL GLY ASP ARG VAL ASN ILE ALA CYS ARG ALA SER SEQRES 3 A 214 GLN GLY ILE SER SER ALA LEU ALA TRP TYR GLN GLN LYS SEQRES 4 A 214 PRO GLY LYS ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 A 214 ASN LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 A 214 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 A 214 GLN PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN GLN PHE SEQRES 8 A 214 ASN SER TYR PRO LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 A 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 A 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 A 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 A 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 A 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 A 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 A 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 A 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 A 214 PHE ASN ARG GLY GLU CYS SEQRES 1 B 462 GLN VAL LYS LEU LEU GLU GLN SER GLY ALA GLU VAL LYS SEQRES 2 B 462 LYS PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER SEQRES 3 B 462 GLY TYR SER PHE THR SER TYR GLY LEU HIS TRP VAL ARG SEQRES 4 B 462 GLN ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE SEQRES 5 B 462 SER ALA GLY THR GLY ASN THR LYS TYR SER GLN LYS PHE SEQRES 6 B 462 ARG GLY ARG VAL THR PHE THR ARG ASP THR SER ALA THR SEQRES 7 B 462 THR ALA TYR MET GLY LEU SER SER LEU ARG PRO GLU ASP SEQRES 8 B 462 THR ALA VAL TYR TYR CYS ALA ARG ASP PRO TYR GLY GLY SEQRES 9 B 462 GLY LYS SER GLU PHE ASP TYR TRP GLY GLN GLY THR LEU SEQRES 10 B 462 VAL THR VAL SER SER ALA SER PRO THR SER PRO LYS VAL SEQRES 11 B 462 PHE PRO LEU SER LEU ASP SER THR PRO GLN ASP GLY ASN SEQRES 12 B 462 VAL VAL VAL ALA CYS LEU VAL GLN GLY PHE PHE PRO GLN SEQRES 13 B 462 GLU PRO LEU SER VAL THR TRP SER GLU SER GLY GLN ASN SEQRES 14 B 462 VAL THR ALA ARG ASN PHE PRO PRO SER GLN ASP ALA SER SEQRES 15 B 462 GLY ASP LEU TYR THR THR SER SER GLN LEU THR LEU PRO SEQRES 16 B 462 ALA THR GLN CYS PRO ASP GLY LYS SER VAL THR CYS HIS SEQRES 17 B 462 VAL LYS HIS TYR THR ASN PRO SER GLN ASP VAL THR VAL SEQRES 18 B 462 PRO CYS PRO VAL PRO PRO PRO PRO PRO CYS CYS HIS PRO SEQRES 19 B 462 ARG LEU SER LEU HIS ARG PRO ALA LEU GLU ASP LEU LEU SEQRES 20 B 462 LEU GLY SER GLU ALA ASN LEU THR CYS THR LEU THR GLY SEQRES 21 B 462 LEU ARG ASP ALA SER GLY ALA THR PHE THR TRP THR PRO SEQRES 22 B 462 SER SER GLY LYS SER ALA VAL GLN GLY PRO PRO GLU ARG SEQRES 23 B 462 ASP LEU CYS GLY CYS TYR SER VAL SER SER VAL LEU PRO SEQRES 24 B 462 GLY CYS ALA GLN PRO TRP ASN HIS GLY GLU THR PHE THR SEQRES 25 B 462 CYS THR ALA ALA HIS PRO GLU LEU LYS THR PRO LEU THR SEQRES 26 B 462 ALA ASN ILE THR LYS SER GLY ASN THR PHE ARG PRO GLU SEQRES 27 B 462 VAL HIS LEU LEU PRO PRO PRO SER GLU GLU LEU ALA LEU SEQRES 28 B 462 ASN GLU LEU VAL THR LEU THR CYS LEU ALA ARG GLY PHE SEQRES 29 B 462 SER PRO LYS ASP VAL LEU VAL ARG TRP LEU GLN GLY SER SEQRES 30 B 462 GLN GLU LEU PRO ARG GLU LYS TYR LEU THR TRP ALA SER SEQRES 31 B 462 ARG GLN GLU PRO SER GLN GLY THR THR THR PHE ALA VAL SEQRES 32 B 462 THR SER ILE LEU ARG VAL ALA ALA GLU ASP TRP LYS LYS SEQRES 33 B 462 GLY ASP THR PHE SER CYS MET VAL GLY HIS GLU ALA LEU SEQRES 34 B 462 PRO LEU ALA PHE THR GLN LYS THR ILE ASP ARG LEU ALA SEQRES 35 B 462 GLY LYS PRO THR HIS VAL ASN VAL SER VAL VAL MET ALA SEQRES 36 B 462 GLU VAL ASP GLY THR CYS TYR SEQRES 1 C 214 GLU LEU VAL MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 C 214 SER VAL GLY ASP ARG VAL ASN ILE ALA CYS ARG ALA SER SEQRES 3 C 214 GLN GLY ILE SER SER ALA LEU ALA TRP TYR GLN GLN LYS SEQRES 4 C 214 PRO GLY LYS ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 C 214 ASN LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 C 214 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 C 214 GLN PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN GLN PHE SEQRES 8 C 214 ASN SER TYR PRO LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 C 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 C 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 C 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 C 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 C 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 C 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 C 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 C 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 C 214 PHE ASN ARG GLY GLU CYS SEQRES 1 D 462 GLN VAL LYS LEU LEU GLU GLN SER GLY ALA GLU VAL LYS SEQRES 2 D 462 LYS PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER SEQRES 3 D 462 GLY TYR SER PHE THR SER TYR GLY LEU HIS TRP VAL ARG SEQRES 4 D 462 GLN ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE SEQRES 5 D 462 SER ALA GLY THR GLY ASN THR LYS TYR SER GLN LYS PHE SEQRES 6 D 462 ARG GLY ARG VAL THR PHE THR ARG ASP THR SER ALA THR SEQRES 7 D 462 THR ALA TYR MET GLY LEU SER SER LEU ARG PRO GLU ASP SEQRES 8 D 462 THR ALA VAL TYR TYR CYS ALA ARG ASP PRO TYR GLY GLY SEQRES 9 D 462 GLY LYS SER GLU PHE ASP TYR TRP GLY GLN GLY THR LEU SEQRES 10 D 462 VAL THR VAL SER SER ALA SER PRO THR SER PRO LYS VAL SEQRES 11 D 462 PHE PRO LEU SER LEU ASP SER THR PRO GLN ASP GLY ASN SEQRES 12 D 462 VAL VAL VAL ALA CYS LEU VAL GLN GLY PHE PHE PRO GLN SEQRES 13 D 462 GLU PRO LEU SER VAL THR TRP SER GLU SER GLY GLN ASN SEQRES 14 D 462 VAL THR ALA ARG ASN PHE PRO PRO SER GLN ASP ALA SER SEQRES 15 D 462 GLY ASP LEU TYR THR THR SER SER GLN LEU THR LEU PRO SEQRES 16 D 462 ALA THR GLN CYS PRO ASP GLY LYS SER VAL THR CYS HIS SEQRES 17 D 462 VAL LYS HIS TYR THR ASN PRO SER GLN ASP VAL THR VAL SEQRES 18 D 462 PRO CYS PRO VAL PRO PRO PRO PRO PRO CYS CYS HIS PRO SEQRES 19 D 462 ARG LEU SER LEU HIS ARG PRO ALA LEU GLU ASP LEU LEU SEQRES 20 D 462 LEU GLY SER GLU ALA ASN LEU THR CYS THR LEU THR GLY SEQRES 21 D 462 LEU ARG ASP ALA SER GLY ALA THR PHE THR TRP THR PRO SEQRES 22 D 462 SER SER GLY LYS SER ALA VAL GLN GLY PRO PRO GLU ARG SEQRES 23 D 462 ASP LEU CYS GLY CYS TYR SER VAL SER SER VAL LEU PRO SEQRES 24 D 462 GLY CYS ALA GLN PRO TRP ASN HIS GLY GLU THR PHE THR SEQRES 25 D 462 CYS THR ALA ALA HIS PRO GLU LEU LYS THR PRO LEU THR SEQRES 26 D 462 ALA ASN ILE THR LYS SER GLY ASN THR PHE ARG PRO GLU SEQRES 27 D 462 VAL HIS LEU LEU PRO PRO PRO SER GLU GLU LEU ALA LEU SEQRES 28 D 462 ASN GLU LEU VAL THR LEU THR CYS LEU ALA ARG GLY PHE SEQRES 29 D 462 SER PRO LYS ASP VAL LEU VAL ARG TRP LEU GLN GLY SER SEQRES 30 D 462 GLN GLU LEU PRO ARG GLU LYS TYR LEU THR TRP ALA SER SEQRES 31 D 462 ARG GLN GLU PRO SER GLN GLY THR THR THR PHE ALA VAL SEQRES 32 D 462 THR SER ILE LEU ARG VAL ALA ALA GLU ASP TRP LYS LYS SEQRES 33 D 462 GLY ASP THR PHE SER CYS MET VAL GLY HIS GLU ALA LEU SEQRES 34 D 462 PRO LEU ALA PHE THR GLN LYS THR ILE ASP ARG LEU ALA SEQRES 35 D 462 GLY LYS PRO THR HIS VAL ASN VAL SER VAL VAL MET ALA SEQRES 36 D 462 GLU VAL ASP GLY THR CYS TYR CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000